findmyKOL
Clinical trialNCT04713072CompletedPhase 2Interventional

A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic Arthritis

SponsorACELYRIN Inc.Enrollment129Psoriatic Arthritis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria
  • Lkh-Univ. Klinikum Graz Universitätsklinik Für Innere Medizin Klinische Abteilung Für Rheumatologie Und Immunologie

    Graz, Austria

  • Medizinische Universität Innsbruck/tirol Kliniken Gmbh Universitätsklinik Für Innere Medizin Ii

    Innsbruck, Austria

  • Vienna Medical University Department of Internal Medicine Iii Division of Rheumatology

    Vienna, Austria

Belgium
  • Katholieke Universiteit Leuven

    Leuven, Belgium

Czechia
  • Vesalion S.R.O.

    Ostrava, Czechia

  • Revmatologický Ústav

    Prague, Czechia

  • Medical Plus S.R.O.

    Uherské Hradiště, Czechia

  • Pv Medical Services S.R.O.

    Zlín, Czechia

Germany
  • Rheumatologische Schwerpunktpraxis

    Berlin, Germany

  • Schlosspark Klinik

    Berlin, Germany

  • Centrum Für Innovative Diagnostik Und Therapie Rheumatologie/immunologie

    Frankfurt, Germany

  • Universitätsklinikum Freiburg

    Freiburg im Breisgau, Germany

  • Rheumazentrum Ruhrgebiet Herne

    Herne, Germany

  • Klinikum Der Universität München Rheumatologie

    München, Germany

  • Rheumazentrum Ratingen

    Ratingen, Germany

Hungary
  • Qualiclinic Kft.

    Budapest, Hungary

  • Cru Hungary Ltd

    Miskolc, Hungary

  • Máv Kórház És Rendelőintézet, Reumtólegia

    Szolnok, Hungary

  • Vital Medical Center

    Veszprém, Hungary

Poland
  • Nasz Lekarz Ośrodek Badań Klinicznych

    Bydgoszcz, Poland

  • Pratia Mcm Krakow

    Krakow, Poland

  • Centrum Medyczne Amed Oddział W Łodzi

    Lodz, Poland

  • Etyka Ośrodek Badań Klinicznych

    Olsztyn, Poland

  • Etg Skierniewice

    Skierniewice, Poland

  • Centrum Medyczne Amed

    Warsaw, Poland

  • Etg Warszawa

    Warsaw, Poland

Spain
  • Complejo Hospitalario Universitario de A Coruña

    A Coruña, Spain

  • Hospital Universitario Reina Sofía 1 Planta Derecha Servicio Reumatología- Imibic

    Córdoba, Spain

  • Cliníca Ceta - Unidad de Ensayos Clínicos

    Madrid, Spain

  • Hospital Parc Tauli de Sabadell

    Sabadell, Spain

  • Complejo Hospitalario Universitario de Santiago de Compostela Hospital Clinico Universitario

    Santiago de Compostela, Spain

  • Hospital Quironsalud Infanta Luisa Unidad de Investigación de Reumatología

    Seville, Spain

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
4 Aug 2020
Primary completion
1 Oct 2021
Completion
27 Jan 2022
Last update posted
9 Feb 2024
Registered enrollment
129
Registry id
NCT04713072
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.